Belgian Drugmaker in Talks on $800 Million Debt Deal

(Bloomberg) -- Pharmaceuticals firm SERB plans to line up $800 million to finance an acquisition in the U.S. and may turn to direct lenders to fund part of the deal, according to three people with ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.